Sumitomo Mitsui Trust Group, Inc.
Institutional investor · Portfolio as of Q1 2019
Top Holdings974 positions
Apple Inc | 19.7M | $3.7B | 3.5% | $45.22 | 0.00% | 1 qtr | First report 0 |
Microsoft Corp | 29M | $3.4B | 3.2% | $110.12 | 0.00% | 1 qtr | First report 0 |
Amazon.com Inc | 1.7M | $3.1B | 2.9% | $89.04 | 0.00% | 1 qtr | First report 0 |
Facebook Inc | 9.5M | $1.6B | 1.5% | $165.11 | 0.00% | 1 qtr | First report 0 |
Johnson & Johnson | 10.9M | $1.5B | 1.4% | $113.77 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc | 1.2M | $1.5B | 1.4% | $58.12 | 0.00% | 1 qtr | First report 0 |
Alphabet Inc | 1.2M | $1.4B | 1.3% | $58.29 | 0.00% | 1 qtr | First report 0 |
Exxon Mobil Corp | 17M | $1.4B | 1.3% | $58.62 | 0.00% | 1 qtr | First report 0 |
JPMorgan Chase & Co | 13M | $1.3B | 1.2% | $82.70 | 0.00% | 1 qtr | First report 0 |
ISHARES GOLD TRUST ETF | 96.6M | $1.2B | 1.1% | $24.76 | 0.00% | 1 qtr | First report 0 |
Visa Inc | 7.2M | $1.1B | 1.0% | $148.12 | 0.00% | 1 qtr | First report 0 |
Procter & Gamble Co/The | 10.2M | $1.1B | 1.0% | $85.93 | 0.00% | 1 qtr | First report 0 |
Berkshire Hathaway Inc | 5.1M | $1B | 1.0% | $200.89 | 0.00% | 1 qtr | First report 0 |
UnitedHealth Group Inc | 4.1M | $1B | 0.9% | $217.04 | 0.00% | 1 qtr | First report 0 |
Intel Corp | 18.8M | $1B | 0.9% | $46.51 | 0.00% | 1 qtr | First report 0 |
Verizon Communications Inc | 16.8M | $991.6M | 0.9% | $38.16 | 0.00% | 1 qtr | First report 0 |
Bank of America Corp | 35.8M | $987.5M | 0.9% | $23.03 | 0.00% | 1 qtr | First report 0 |
Pfizer Inc | 23.2M | $987.2M | 0.9% | $28.06 | 0.00% | 1 qtr | First report 0 |
Cisco Systems Inc/Delaware | 18.2M | $980.2M | 0.9% | $43.51 | 0.00% | 1 qtr | First report 0 |
Chevron Corp | 7.9M | $976.7M | 0.9% | $89.78 | 0.00% | 1 qtr | First report 0 |
Sumitomo Mitsui Trust Group, Inc. manages $108.1B across 974 positions as of Q1 2019. Top holdings: AAPL (3.5%), MSFT (3.2%), AMZN (2.9%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3.5/5.0.
First quarter we have for this fund: 974 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $108.1B across 974 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR